Join the Asthma group to help and get support from people like you.
Asthma News (Page 7)
Related terms: Bronchial Asthma, Exercise-induced asthma, Wheezing
Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
FRIDAY, July 26, 2024 – Bad news for Olympians headed to Paris – high levels of ozone pollution and grass pollen are likely during the upcoming games if hot, sunny weather prevails, researchers...
Wildfires Are Creating Hazardous Air Conditions in Western North America
FRIDAY, July 26, 2024 – Wildfires raging across the western parts of the United States and Canada are prompting air quality alerts and evacuation orders. Smoke and haze have filled the skies in...
Wildfires in Western U.S., Canada Create Hazardous Air Conditions
THURSDAY, July 25, 2024 – Wildfires raging in several states and Canada are triggering air quality alerts and evacuation orders across the western parts of the United States. Smoke and haze have...
Childhood Air Pollution Exposure Tied to Later Bronchitic Symptoms
THURSDAY, July 25, 2024 – Childhood exposure to air pollution is associated with adult bronchitic symptoms, according to a study published online June 25 in the American Journal of Respiratory and ...
Huge Warehouses Can Create Unhealthy Neighborhoods
WEDNESDAY, July 24, 2024 – Online retail giants like Amazon have made it easier for people to buy what they want when they want it, but that convenience comes at a cost to people’s health, a new s...
How Early Antibiotic Use Could Raise Kids' Asthma Risk
TUESDAY, July 16, 2024 – Early exposure to antibiotics might increase a kid’s risk of asthma by altering their gut bacteria, a new mouse study finds. Antibiotics could specifically lower gut p...
Current Asthma at Age 7 Linked to Chronic Rhinosinusitis in Middle Age
TUESDAY, July 16, 2024 – Current asthma, head colds, and tonsillitis at age 7 years are associated with chronic rhinosinusitis (CRS) at midlife, according to a study published online July 10 in...
Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma
WILMINGTON, Del.--(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients wi...
Tezspire Approved for Self-Administration in the U.S. With a New Pre-filled Pen
Now Offers Patients the Choice of Administration at Home or in a Doctor's Office THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ – Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S....
FDA Approves Airsupra (albuterol/budesonide) Metered-Dose Inhaler to Reduce the Risk of Asthma Exacerbations
January 11, 2023 – Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of...
FDA Approves Tezspire (tezepelumab) for Severe Asthma
17 December 2021 – AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with s...
FDA Expands Approval of Dupixent (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
TARRYTOWN, N.Y. and PARIS, Oct. 20, 2021 /PRNewswire/ – Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting...
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma
London UK 9 September 2020 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy...
FDA Medwatch Alert: FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast
March 4, 2020 - The U.S. Food and Drug Administration today announced that it is requiring a boxed warning – the agency’s most prominent warning – for montelukast (sold under the brand name Singulair ...
FDA Approves Fasenra Pen (benralizumab) Pre-Filled Auto-Injector for Self-Administration
October 4, 2019 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector...
Further information
Related condition support groups
Asthma - Maintenance, Asthma - Acute
Related drug support groups
prednisone, methylprednisolone, albuterol, caffeine, triamcinolone, Dupixent, Medrol, Xolair, dexamethasone, view more... Trelegy Ellipta, fluticasone, omalizumab, montelukast, budesonide, dupilumab